Shilpa Medicare Limited has informed the Exchange about Redemption of Non-Convertible Debentures ( NCD ) by Shilpa Pharma Lifesciences Limited ( SPL )
SHILPAMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shilpa Medicare has informed the exchanges that its wholly-owned subsidiary, Shilpa Pharma Lifesciences Limited (SPL), has fully redeemed all its outstanding Non-Convertible Debentures (NCDs) on 11 August 2025. The NCDs were senior, secured, rated, unlisted, and redeemable in nature, originally referenced in an intimation dated 12 August 2024. As a result, SPL now has zero outstanding NCDs on its books. This marks the complete repayment of the subsidiary's debenture obligations ahead of (or on) the scheduled maturity date.
Positive for shareholders — the subsidiary has cleared all its debenture debt, which reduces interest costs and strengthens the consolidated balance sheet of Shilpa Medicare, with no remaining NCD obligations at the subsidiary level.